Skip to main content
. 2022 Apr 7;41:127. doi: 10.1186/s13046-022-02340-2

Table 1.

Quality assessment of included clinical studies

Ref Author Selection Comparability Outcomes Quality score
[17] Asahi Y ★★★★ 6/9
[18] Goeppert B ★★★★ ★★ 7/9
[19] Hasita H ★★★★ ★★ ★★ 8/9
[20] Kim HD ★★★ ★★ 6/9
[21] Kim R ★★★ ★★ ★★ 7/9
[22] Kitano Y ★★★★ ★★ ★★ 8/9
[23] Lu JC ★★★★ ★★ 7/9
[24] Miura T ★★★★ ★★ ★★ 9/9
[25] Oshikiri T ★★★★ ★★ 7/9
[26] Tian L ★★★★ ★★ ★★★ 9/9
[27] Ueno T ★★★★ ★★ ★★★ 9/9
[28] Vigano L ★★★ ★★ ★★ 7/9
[29] Wu H ★★★★ ★★ ★★ 8/9
[30] Xu YP ★★★★ ★★ ★★ 8/9

All included translational studies reporting oncological outcome were evaluated in accordance with the Newcastle-Ottawa scale [16]. The maximum score of the scale is nine points with studies being categorized as low (0-3 points), moderate (4-6 points) and high quality (7-9 points), respectively